Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2004)
All Articles published online
|
Feb 28, 2007 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Krtolica K, Krajnovic M, Usaj-Knezevic S, Babic D, Jovanovic D, Dimitrijevic B. Comethylation of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1187.htm |
| Number | Citing Articles |
| 1 |
Francesco Crea, Elisa Giovannetti, Filippo Cortesi, Valentina Mey, Sara Nannizzi, Marielle I. Gallegos Ruiz, Simona Ricciardi, Mario Del Tacca, Godefridus J. Peters, Romano Danesi. Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines. Molecular Cancer Therapeutics 2009; 8(7): 1964 doi: 10.1158/1535-7163.MCT-09-0027
|
| 2 |
P. Mokarram, M. Zamani, S. Kavousipour, F. Naghibalhossaini, C. Irajie, M. Moradi Sarabi, S. V. Hosseini. Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer. Molecular Biology Reports 2013; 40(5): 3851 doi: 10.1007/s11033-012-2465-3
|
| 3 |
Muriel X. G. Draht, Danny Goudkade, Alexander Koch, Heike I. Grabsch, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte, Kim M. Smits. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0461-8
|
| 4 |
JiaoJiao Ren, GuangXiao Li, Jie Ge, Xia Li, YaShuang Zhao. Is K-ras Gene Mutation a Prognostic Factor for Colorectal Cancer. Diseases of the Colon & Rectum 2012; 55(8): 913 doi: 10.1097/DCR.0b013e318251d8d9
|
| 5 |
A. SYED SAMEER, SAFIYA ABDULLAH, SANIYA NISSAR, ROOHI RASOOL, ZAFFAR A. SHAH, DIL AFROZE, NISSAR A. CHOWDRI, MUSHTAQ A. SIDDIQI. The blues of P(16)INK(4a): Aberrant promoter methylation and association with colorectal cancer in the Kashmir valley. Molecular Medicine Reports 2012; 5(4): 1053 doi: 10.3892/mmr.2012.740
|
| 6 |
A. V. Belyaeva, G. A. Yanus, E. N. Suspitsyn, O. A. Zaitseva, O. S. Yatsuk, A. B. Moiseenko, A. V. Gulyaev, E. N. Imyanitov. Age-related and clinicopathological features of colorectal cancer associated with K-ras gene status. Advances in Gerontology 2012; 2(4): 306 doi: 10.1134/S2079057012040030
|
| 7 |
Anna M. Dahlin, Richard Palmqvist, Maria L. Henriksson, Maria Jacobsson, Vincy Eklöf, Jörgen Rutegård, Åke Öberg, Bethany R. Van Guelpen. The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status. Clinical Cancer Research 2010; 16(6): 1845 doi: 10.1158/1078-0432.CCR-09-2594
|
| 8 |
Agnès Neuville, Céline Nicolet, Nicolas Meyer, Anne Schneider, Michèle Legrain, Cécile Brigand, Bernard Duclos, Philippe Bachellier, Pierre Oudet, Jean-Pierre Bellocq, Michèle Kedinger, Marie-Pierre Gaub, Dominique Guenot. Histologic characteristics of non–microsatellite-instable colon adenomas correlate with distinct molecular patterns. Human Pathology 2011; 42(2): 244 doi: 10.1016/j.humpath.2010.07.003
|
| 9 |
Afsane Bahrami, Seyed Mahdi Hassanian, Majid Khazaei, Masoumeh Gharib, Mahsa Rahmani, Hamid Fiuji, Mir Hadi Jazayeri, Mehrdad Moetamani-Ahmadi, Gordon A Ferns, Amir Avan. The 9p21 locus as a potential therapeutic target and prognostic marker in colorectal cancer. Pharmacogenomics 2018; 19(5): 463 doi: 10.2217/pgs-2017-0096
|
| 10 |
Sally M. Shalaby, Amal S. El-Shal, Lobna A. Abdelaziz, Eman Abd-Elbary, Mostafa M. Khairy. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients. Gene 2018; 644: 66 doi: 10.1016/j.gene.2017.10.056
|
| 11 |
Kaori Shima, Teppei Morikawa, Yoshifumi Baba, Katsuhiko Nosho, Maiko Suzuki, Mai Yamauchi, Marika Hayashi, Edward Giovannucci, Charles S. Fuchs, Shuji Ogino. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers. Cancer Causes & Control 2011; 22(2): 301 doi: 10.1007/s10552-010-9698-z
|
| 12 |
Pensri Saelee, Ubol Chuensumran, Sopit Wongkham, Sunanta Chariyalertsak, Danai Tiwawech, Songsak Petmitr. Hypermethylation of Suppressor of Cytokine Signaling 1 in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(7): 3489 doi: 10.7314/APJCP.2012.13.7.3489
|
| 13 |
A.M. Cesinaro, G. Sartori, M. Migaldi, L. Schirosi, G. Pellacani, G. Collina, A. Maiorana. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas. Pathology 2012; 44(4): 313 doi: 10.1097/PAT.0b013e328353a0ff
|
| 14 |
Xiaotu Ma, Yi-Wei Wang, Michael Q Zhang, Adi F Gazdar. DNA methylation data analysis and its application to cancer research. Epigenomics 2013; 5(3): 301 doi: 10.2217/epi.13.26
|
| 15 |
EBRU ESIN YORUKER, UFUK MERT, DURSUN BUGRA, SUMER YAMANER, NEJAT DALAY. Promoter and histone methylation and p16INK4A gene expression in colon cancer. Experimental and Therapeutic Medicine 2012; 4(5): 865 doi: 10.3892/etm.2012.683
|
| 16 |
TORBJÖRN K. NILSSON, ZARAH M. LÖF-ÖHLIN, XIAO-FENG SUN. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. International Journal of Oncology 2013; 42(1): 127 doi: 10.3892/ijo.2012.1682
|
| 17 |
Yanliang Li, Zhongchuan Lyu, Lixin Zhao, Hong Cheng, Dongyuan Zhu, Yongsheng Gao, Xiuwan Shang, Huaijie Shi. Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review. Tumor Biology 2015; 36(3): 1595 doi: 10.1007/s13277-014-2752-9
|
| 18 |
Tamsin R M Lannagan, Young K Lee, Tongtong Wang, Jatin Roper, Mark L Bettington, Lochlan Fennell, Laura Vrbanac, Lisa Jonavicius, Roshini Somashekar, Krystyna Gieniec, Miao Yang, Jia Q Ng, Nobumi Suzuki, Mari Ichinose, Josephine A Wright, Hiroki Kobayashi, Tracey L Putoczki, Yoku Hayakawa, Simon J Leedham, Helen E Abud, Ömer H Yilmaz, Julie Marker, Sonja Klebe, Pratyaksha Wirapati, Siddhartha Mukherjee, Sabine Tejpar, Barbara A Leggett, Vicki L J Whitehall, Daniel L Worthley, Susan L Woods. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut 2019; 68(4): 684 doi: 10.1136/gutjnl-2017-315920
|
| 19 |
ADAM ELZAGHEID, ABDELBASET BUHMEIDA, MATTI LAATO, OMRAN EL‐FAITORI, KARI SYRJÄNEN, YRJÖ COLLAN, SEPPO PYRHÖNEN. Loss of E‐cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma. APMIS 2012; 120(7): 539 doi: 10.1111/j.1600-0463.2011.02863.x
|
| 20 |
Giovanna De Maglio, Mariaelena Casagrande, Michela Guardascione, Caterina Fontanella, Stefania Eufemia Lutrino, Karim Rihawi, Federica Edith Pisa, Francesco Tuniz, Gianpiero Fasola, Stefano Pizzolitto, Giuseppe Aprile. MGMTpromoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology 2015; 11(8): 1201 doi: 10.2217/fon.15.2
|
| 21 |
Milena Krajnović, Milica Radojković, Radoslav Davidović, Bogomir Dimitrijević, Koviljka Krtolica. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma. Medical Oncology 2013; 30(1) doi: 10.1007/s12032-012-0441-3
|
| 22 |
Milena Krajnović, Maja Peruničić Jovanović, Biljana Mihaljević, Boško Anđelić, Olivera Tarabar, Slavica Knežević‐Ušaj, Koviljka Krtolica. Hypermethylation of p15 Gene in Diffuse – Large B‐Cell Lymphoma: Association with Less Aggressiveness of the Disease. Clinical and Translational Science 2014; 7(5): 384 doi: 10.1111/cts.12162
|
| 23 |
Chen-guo Zheng, Chun Jin, Le-chi Ye, Nian-zhao Chen, Zong-Jing Chen. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis. Tumor Biology 2015; 36(8): 5839 doi: 10.1007/s13277-015-3254-0
|
| 24 |
Emily A Vucic, Carolyn J Brown, Wan L Lam. Epigenetics of cancer progression. Pharmacogenomics 2008; 9(2): 215 doi: 10.2217/14622416.9.2.215
|
| 25 |
Muriel X.G. Draht, Kim M. Smits, Benjamin Tournier, Valerie Jooste, Caroline Chapusot, Beatriz Carvalho, Arjen H.G. Cleven, Sarah Derks, Kim A.D. Wouters, Eric J.T. Belt, Hein B.A.C. Stockmann, Herman Bril, Matty P. Weijenberg, Piet A. van den Brandt, Adriaan P. de Bruïne, James G. Herman, Gerrit A. Meijer, Françoise Piard, Veerle Melotte, Manon van Engeland. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular Oncology 2014; 8(3): 679 doi: 10.1016/j.molonc.2014.01.011
|
| 26 |
Nada Kraguljac Kurtović, Milena Krajnović, Andrija Bogdanović, Nada Suvajdžić, Jelica Jovanović, Bogomir Dimitrijević, Milica Čolović, Koviljka Krtolica. Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells. Medical Oncology 2012; 29(5): 3547 doi: 10.1007/s12032-012-0289-6
|
| 27 |
Pierre Bady, Mauro Delorenzi, Monika E. Hegi. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors. The Journal of Molecular Diagnostics 2016; 18(3): 350 doi: 10.1016/j.jmoldx.2015.11.009
|
| 28 |
Yutaka Hashimoto, Timothy J Zumwalt, Ajay Goel. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer. Epigenomics 2016; 8(5): 685 doi: 10.2217/epi-2015-0013
|
| 29 |
Myoung Sook Kim, Juna Lee, David Sidransky. DNA methylation markers in colorectal cancer. Cancer and Metastasis Reviews 2010; 29(1): 181 doi: 10.1007/s10555-010-9207-6
|
| 30 |
Oztürk Ozdemir, Esin Yildiz, Semih Ayan, Eylem Gul, Gökhan Gokce, Fazilet Yildiz, Binnur Koksal. Promoter hypermethylation of tissue specific tumor supressor genes and point mutation in K-ras, c-myc proto-oncogenes in urinary (transitional cell) bladder carcinoma. Health 2010; 2(08): 850 doi: 10.4236/health.2010.28128
|
| 31 |
Gustavo A. Laporte, Natalia M. Leguisamo, Antonio N. Kalil, Jenifer Saffi. Clinical importance of DNA repair in sporadic colorectal cancer. Critical Reviews in Oncology/Hematology 2018; 126: 168 doi: 10.1016/j.critrevonc.2018.03.017
|
| 32 |
Stefan David, Stephen J. Meltzer. Pre-Invasive Disease: Pathogenesis and Clinical Management. 2011; : 41 doi: 10.1007/978-1-4419-6694-0_4
|
| 33 |
Kaori Shima, Katsuhiko Nosho, Yoshifumi Baba, Mami Cantor, Jeffrey A. Meyerhardt, Edward L. Giovannucci, Charles S. Fuchs, Shuji Ogino. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. International Journal of Cancer 2011; 128(5): 1080 doi: 10.1002/ijc.25432
|
| 34 |
Yan-Zhi Chen, Dan Liu, Yu-Xia Zhao, He-Tong Wang, Ya Gao, Ying Chen. Relationships Betweenp16Gene Promoter Methylation and Clinicopathologic Features of Colorectal Cancer: A Meta-Analysis of 27 Cohort Studies. DNA and Cell Biology 2014; 33(10): 729 doi: 10.1089/dna.2013.2253
|
| 35 |
Guoren Deng, Sanjay Kakar, Hirofumi Tanaka, Koji Matsuzaki, Soichiro Miura, Marvin H. Sleisenger, Young S. Kim. Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. European Journal of Cancer 2008; 44(9): 1290 doi: 10.1016/j.ejca.2008.03.014
|
| 36 |
Muriel XG Draht, Robert R Riedl, Hanneke Niessen, Beatriz Carvalho, Gerrit A Meijer, James G Herman, Manon van Engeland, Veerle Melotte, Kim M Smits. Promoter CpG island methylation markers in colorectal cancer: the road ahead. Epigenomics 2012; 4(2): 179 doi: 10.2217/epi.12.9
|